| J2350 | Injection, ocrelizumab, 1 mg | 290 | $25,900 | $7.6M |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 122,160 | $40 | $5.4M |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 64,460 | $50 | $3.2M |
| 93010 | The provider interprets and reports on the results of a routine 12–lead (or more) electrocardiogram. | 223,510 | $10 | $1.6M |
| J0585 | Injection, onabotulinumtoxina, 1 unit | 2,720 | $530 | $1.4M |
| J2323 | Injection, natalizumab, 1 mg | 240 | $5,890 | $1.4M |
| 93306 | The provider uses transducers to obtain two–dimensional (2D) images of the heart structures through the chest wall. He evaluates the anatomy and function of all four heart chambers, valves, adjacent… | 25,920 | $40 | $958.9K |
| 76811 | The provider performs an ultrasound study using a transabdominal approach to examine the fetus and mother, along with additional examination of the fetal anatomy, such as the heart rate, amniotic… | 9,270 | $90 | $788.1K |
| 99232 | The provider sees a patient for a subsequent hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a moderate level of medical decision making or… | 32,820 | $20 | $754.9K |
| 76816 | The provider reexamines the fetus to follow up on a prior abnormal transabdominal ultrasound. | 16,540 | $50 | $744.3K |